SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-09-023469
Filing Date
2009-04-09
Accepted
2009-04-09 17:00:38
Documents
2
Effectiveness Date
2009-04-09

Document Format Files

Seq Description Document Type Size
1 DEFA14A a09-9814_18k.htm DEFA14A 29714
2 EX-17.1 a09-9814_1ex17d1.htm EX-17.1 5787
  Complete submission text file 0001104659-09-023469.txt   36935
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19700 | Film No.: 09743359
SIC: 2834 Pharmaceutical Preparations